Congresses Diabetes
Past Congresses
- 2026 CWD Orlando
- 2026 NASN Las Vegas
- 2026 PES San Francisco
- 2026 AACE Las Vegas
- 2026 ATTD Barcelona
- 2025 ISPAD Montréal
- 2025 DTM San Francisco
- 2025 FNCE Nashville
- 2025 ADCES Phoenix
- 2025 ADA Chicago
- 2025 CWD Orlando
- 2025 NASN Austin
- 2025 AACE Orlando
- 2025 ISPOR Montréal
- 2025 ATTD Amsterdam
- 2024 ADCES Atlanta
- 2024 CWD Orlando
- 2024 ADA Orlando
- 2024 ATTD Florence
- 2023 ATTD Berlin
ADA New Orleans
Poster
Efficacy and Safety of Inhaled Insulin Versus Rapid-Acting Analogs in Youth With HbA1c ≤9.5%: Subgroup Analysis From INHALE-1
Poster
Exploratory Evaluation of Technosphere Insulin With Automated Insulin Delivery: Impact of Total Daily Dose Algorithms
Poster
Impact of the Inflation Reduction Act on Afrezza Access: A Retrospective Review of TRx Distribution From Baseline Q4 2022 to Q1 2024
Poster
Inhaled Insulin Assessment of Incident Lung Cancer Risk Among Adults With Type 2 Diabetes (T2D) Compared to Other Therapies Using Real-World Evidence
Poster
Inhaled Insulin Demonstrates Earlier Completion of Total Pharmacodynamic Effect Compared to Lispro
Poster
Inhaled Insulin Demonstrates Lower Variability and Faster Onset Compared to Subcutaneous Rapid Acting Analogs
Poster
Inhaled Technosphere Insulin (TI) Compared with Rapid-Acting Analog Insulin (RAA) in Gestational Diabetes
Poster
Participants Achieving HbA1c <8% in Youth Study Report Greater Treatment Satisfaction With Inhaled Insulin vs Rapid-Acting Analogs
Poster